Parametrica Management Ltd Invests $306,000 in Taro Pharmaceutical Industries Ltd. (TARO)

Parametrica Management Ltd purchased a new stake in Taro Pharmaceutical Industries Ltd. (NYSE:TARO) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 2,927 shares of the company’s stock, valued at approximately $306,000.

Several other large investors have also modified their holdings of TARO. Schwab Charles Investment Management Inc. grew its position in shares of Taro Pharmaceutical Industries by 36.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 4,850 shares of the company’s stock valued at $544,000 after purchasing an additional 1,306 shares during the last quarter. Wells Fargo & Company MN grew its position in shares of Taro Pharmaceutical Industries by 11.2% in the second quarter. Wells Fargo & Company MN now owns 1,685 shares of the company’s stock valued at $189,000 after purchasing an additional 170 shares during the last quarter. Alliancebernstein L.P. grew its position in shares of Taro Pharmaceutical Industries by 8.5% in the second quarter. Alliancebernstein L.P. now owns 14,538 shares of the company’s stock valued at $1,629,000 after purchasing an additional 1,144 shares during the last quarter. FMR LLC grew its position in shares of Taro Pharmaceutical Industries by 42.2% in the second quarter. FMR LLC now owns 466,590 shares of the company’s stock valued at $52,286,000 after purchasing an additional 138,353 shares during the last quarter. Finally, California Public Employees Retirement System grew its position in shares of Taro Pharmaceutical Industries by 1.9% in the second quarter. California Public Employees Retirement System now owns 32,800 shares of the company’s stock valued at $3,676,000 after purchasing an additional 600 shares during the last quarter. 11.54% of the stock is currently owned by institutional investors.

Shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) opened at $101.60 on Tuesday. Taro Pharmaceutical Industries Ltd. has a 1 year low of $93.01 and a 1 year high of $128.46. The stock has a market capitalization of $4,070.00, a PE ratio of 19.73 and a beta of 0.62.

ILLEGAL ACTIVITY NOTICE: “Parametrica Management Ltd Invests $306,000 in Taro Pharmaceutical Industries Ltd. (TARO)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another website, it was illegally copied and reposted in violation of United States and international trademark & copyright laws. The legal version of this report can be read at https://www.dispatchtribunal.com/2018/02/20/2927-shares-in-taro-pharmaceutical-industries-ltd-taro-acquired-by-parametrica-management-ltd.html.

About Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply